Discover investment opportunities in Top 20 Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 20 Stocks Under $3 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Top 20 Stocks Under $3 using our Smart AI Filter.
5 stocks found for "Top 20 Stocks Under $3"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.76 | ±100.0% | -6.9 | 0.00% | |||
1.41 | ±67.6% | -20.4 | 0.00% | |||
0.65 | ±52.7% | 7.9 | 4.57% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
0.65 | ±100.0% | — | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Read moreBionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Read moreCannabis grower Organigram Holdings Inc. OGI reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.
Read moreBionano Genomics (BNGO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read moreQ: What are the investment appeals of SNDL in the cannabis sector?
A: SNDL, a cannabis company, appeals to investors interested in leveraging the growth of the legal cannabis market. The company has sought expansion through acquisitions and strategic partnerships, although investors should consider regulatory risks.
Q: How does IDEX's focus on electric vehicles influence its stock value?
A: IDEX's emphasis on the electric vehicle sector aligns with global shifts towards renewable energy. This positioning may suggest potential for growth, but the sector's competitive nature and regulatory environment pose challenges.
Q: Is NOK a stable investment for tech-focused portfolios?
A: NOK, being a key player in network infrastructure and 5G technology, attracts tech-oriented investors. The stock's stability may vary with technological advancements and market demand for new-generation networking solutions.
Q: What sectors might influence ZOM's performance as a stock under $3?
A: ZOM, operating in veterinary health, is potentially driven by growth in pet care spending. Market acceptance of its diagnostic products can vary, impacting performance alongside competitive pressures.
Q: How does exposure to cryptocurrency impact AABB's stock appeal?
A: AABB is involved in developing cryptocurrency solutions, possibly attracting investors interested in digital currencies. However, cryptocurrency's volatility and regulatory uncertainties can pose significant risks.
Q: What growth potential does BNGO offer in the genomics sector?
A: BNGO focuses on genome mapping technology, aiming to transform scientific research and healthcare. Its growth potential is linked to advancements and demand in genomics, though investors should be aware of competition and funding needs.